HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Gustofson Selected Research

ganirelix

11/2006Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome.
1/2006Treatment with gonadotropin-releasing hormone (GnRH) antagonists in women suppressed with GnRH agonist may avoid cycle cancellation in patients at risk for ovarian hyperstimulation syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert L Gustofson Research Topics

Disease

3Endometriosis
08/2017 - 08/2006
2Ovarian Hyperstimulation Syndrome
11/2006 - 01/2006
1Ectopic Pregnancy
12/2013
1Aneuploidy (Aneuploid)
01/2013

Drug/Important Bio-Agent (IBA)

3Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2017 - 01/2006
2Hormones (Hormone)IBA
08/2017 - 01/2013
2IntegrinsIBA
08/2017 - 02/2010
2ganirelixFDA Link
11/2006 - 01/2006
2Leuprolide (Lupron)FDA LinkGeneric
11/2006 - 01/2006
1Methotrexate (Mexate)FDA LinkGeneric
12/2013
1Integrin beta3 (GPIIIa)IBA
02/2010
1VitronectinIBA
02/2010
1Integrin alphaVbeta3IBA
02/2010
1Estradiol (Delestrogen)FDA LinkGeneric
11/2006

Therapy/Procedure

1Therapeutics
02/2010
1Lasers (Laser)
08/2006
1Trabeculectomy (Trabeculoplasty)
08/2006